News

GelStat working deal to expand product portfolio

BY Michael Johnsen

PALM CITY, Fla. — GelStat on Monday announced its intent to acquire the rights to multiple products from Larry Gershman. The transaction is subject to the completion of standard due diligence and closing conditions and is expected to close within 45 days.

"This is an important milestone for GelStat as it is an extremely synergistic transaction that brings products and management depth to the company," stated Gerald Kieft, CEO GelStat. "It also validates GelStat’s strategy to aggressively pursue acquisition targets that possess products with proven science, marketing or distribution," he said. "Additionally, it fits into the company’s goal of becoming a global healthcare products company. Gershman’s vast experience as a senior executive at top marketing firms and healthcare companies is exactly what GelStat needed to take the company to the next level. He has led many consumer product launches in the past that have generated tens of millions of dollars in revenue."

The products include an appetite suppressant chewing gum, an energy product, a joint pain lubricant and cartilage renewal product and a silver nano-particles anti-microbial and anti-acne face product.

Upon closing of the transaction, Gershman will assume the position as CEO and chairman GelStat. Kieft, the company’s present CEO, will assume the position of CFO. 


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Top minds in retail to headline exclusive DSN-Mack Elevation event

BY Rob Eder

LAS VEGAS — Winners create the future; losers let the future happen to them. To help leading retailers and vendors better understand how to leverage mutual assets and create a winning future — and optimize meetings at NACDS Total Store Expo — the Mack Elevation Forum and the Drug Store News Group will co-host an exclusive one-day summit, here, at the Westin Hotel, Aug. 9. A special kickoff for NACDS Total Store Expo, "The Elevation Forum: The Seven Ideas to Create the Future,” brings together some of the top minds in retail to give attendees a grasp of emerging industry best practices in strategic sales, marketing, merchandising and retail consumer packaged goods strategy.

Highlights of the event will include:

  • Ken Martindale, Rite Aid president and COO — how to re-imagine and reinvent your business;
  • Google head of industry and retail Ted Souder — how to build an infectious brand;
  • Walgreens’ Shannon Curtin, VP beauty, personal care and seasonal — the best practices for retailer-vendor new item co-creation;
  • Chase Wales, director and category leader of health and beauty at Amazon — how to create a game-changing culture through speed, agility and new digital consumer experience;
  • Dennis Moore, Nielsen’s SVP analytics — the future of big data and how to synthesize social media, market basket and syndicated data;
  • Mark Jones of IDEO, makers of the first mouse for Apple and the first Treo — how to create a culture of innovation; and
  • IRI VP and general manager of strategy Larry Levin — incremental growth through localized assortments.

"They best win through joint development, and they are in a constant dialogue with their partners," noted Dan Mack, founder and leader of Mack Elevation Forum, who will moderate the forum. "They unleash growth by creating the future with their retail partners."

"[Like] the TED series of conferences, our mission is to create a similar experience for our industry," noted DSN publisher Wayne Bennett.

"It is not about the size of your organization," Mack noted. "It’s about the value you create with the consumer, the retailers and the industry. This is an event for leaders who are looking for an edge."

To register for the event, or to learn more, visit ElevationForum.com.

For sponsorship opportunities, contact Drug Store News Group publisher Wayne Bennett at [email protected]

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Study supports low-calorie sweeteners as way to help prevent, manage diabetes

BY Alaric DeArment

ATLANTA — Low-calorie sweeteners can be used to prevent and manage Type 2 diabetes, according to a new study.

The study, conducted by a group of researchers at the Baylor College of Medicine and published in the summer 2013 issue of the journal U.S. Endocrinology, examined the role between excess weight gain and management and prevention of Type 2 diabetes from available literature.

The study found that replacing added sugars with low-calorie sweeteners can reduce the rise in blood-glucose levels and aid in controlling weight and that the sweeteners don’t affect weight gain because they have no adverse effects on insulin and hormone levels. They also can benefit dental health and be used to manage high blood-sugar in people who don’t have Type 2 diabetes.

"This review adds to the growing body of scientific evidence suggesting that low-calorie sweeteners can play an important role in the management of diabetes," Calorie Control Council president Haley Curtis Stevens said; the council is an association of manufacturers of low-calorie, sugar-free, reduced-fat and "light" foods and beverages. "Foods and beverages sweetened with low-calorie sweeteners offer lower-calorie alternatives that can be important tools in the fight against obesity and diabetes."


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

J.Jefferson-Loveday says:
Jun-12-2013 12:46 pm

Full article is freely available for pdf download at dedicated website of US Endocrinology- http://www.touchendocrinology.com/articles/role-low-calorie-sweeteners-diabetes

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?